Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
Holding RPRX?
Track your performance easily

Royalty Pharma (RPRX) Technical Analysis

830 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Royalty Pharma PLC’s (RPRX) Moving Averages Convergence Divergence (MACD) indicator is 0.12, suggesting Royalty Pharma PLC is a Buy.
Royalty Pharma PLC’s (RPRX) 20-Day exponential moving average is 28.13, while Royalty Pharma PLC’s (RPRX) share price is $28.21, making it a Buy.
Royalty Pharma PLC’s (RPRX) 50-Day exponential moving average is 27.81, while Royalty Pharma PLC’s (RPRX) share price is $28.21, making it a Buy.

Royalty Pharma (RPRX) Pivot Points

Sep 20, 2024, 07:34 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
27.80
27.99
28.11
28.30
28.42
28.61
28.73
Fibonacci
27.99
28.11
28.18
28.30
28.42
28.49
28.61
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Royalty Pharma (RPRX) Moving Averages

Sep 20, 2024, 07:34 AM
Period
Simple
Exponential
MA5
28.00Buy
28.13Buy
MA10
28.17Buy
28.17Buy
MA20
28.36Sell
28.13Buy
MA50
27.77Buy
27.81Buy
MA100
27.34Buy
27.66Buy
MA200
27.91Buy
27.66Buy
Royalty Pharma PLC’s (RPRX) 10-Day exponential moving average is 28.17, while Royalty Pharma PLC’s (RPRX) share price is $28.21, making it a Buy.
Royalty Pharma PLC’s (RPRX) 100-Day exponential moving average is 27.66, while Royalty Pharma PLC’s (RPRX) share price is $28.21, making it a Buy.
Royalty Pharma PLC’s (RPRX) stock price is $28.21 and Royalty Pharma PLC’s (RPRX) 50-day simple moving average is 27.77, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) stock price is $28.21 and Royalty Pharma PLC’s (RPRX) 100-day simple moving average is 27.34, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) stock price is $28.21 and Royalty Pharma PLC’s (RPRX) 200-day simple moving average is 27.91, creating a Buy signal.

Royalty Pharma (RPRX) Technical Indicators

Sep 20, 2024, 07:34 AM
Name
Value
Implied Action
RSI (14)
52.52
Neutral
STOCH (9,6)
42.14
Neutral
STOCHRSI (14)
40.04
Neutral
MACD (12,26)
0.12
Buy
ADX (14)
19.50
Buy
Williams %R
-61.38
Buy
CCI (14)
-16.71
Neutral
ATR (14)
0.52
-
Ultimate Oscillator
42.01
Neutral
ROC
-2.08
Sell
Royalty Pharma PLC’s (RPRX) Relative Strength Index (RSI) is 52.52, creating a Neutral signal.
Royalty Pharma PLC’s (RPRX) Trend Strength Indicator (ADX) is 19.50, creating a Buy signal.
Royalty Pharma PLC’s (RPRX) Commodity Channel Index (CCI) is -16.71, creating a Neutral signal.
Royalty Pharma PLC’s (RPRX) Price Rate of Change (ROC) is -2.08, creating a Sell signal.

FAQ

Is RPRX a Buy, Hold, or Sell?
Based on RPRX’s technical indicators, RPRX is a Strong Buy.
    What is RPRX’s RSI (14)?
    RPRX’s RSI (14) is 52.52, which suggests RPRX is a Neutral.
      What is RPRX’s MACD?
      RPRX’s MACD is 0.12, which suggests RPRX is a Buy.
        What is RPRX’s 5-day moving average?
        RPRX’s 5-day moving average is 28.00, which suggests RPRX is a Buy.
          What is RPRX’s 20-day moving average?
          RPRX 20-day moving average is 28.36, which suggests RPRX is a Sell.
            What is RPRX’s 50-day moving average?
            RPRX’s 50-day moving average is 27.77, which suggests RPRX is a Buy.
              What is RPRX’s 200-day moving average?
              RPRX’s 200-day moving average is 27.91, which suggests RPRX is a Buy.
                What is RPRX’s Williams % R (14)?
                RPRX’s Williams % R (14) is -61.38, which suggests RPRX is a Buy.
                  What is RPRX’s CCI (14)?
                  RPRX’s CCI (14) is -16.71, which suggests RPRX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis